Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-20-002058

Options or other derivatives

  • Director acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gray Cameron Director 2020-01-02 Grant or award · Stock Option (right to buy) +8,000 8,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…